Expanding the knowledge of Helicobacter pylori – new directions, new challenges
KeywordsHelicobacter pylori, genetics, pathogenicity, analysis,
Helicobacter pylori (H. pylori) infection is prevalent worldwide. As it is a known carcinogen, causing multitude of gastrointestinal end extra-gastric disorders, the eradication therapy is now indicated for every patient diagnosed with this infection. This approach may prove however to be improper, since it is now known, that not every strain of this species is pathogenic, therapy may be unsuccessful and drug resistance is ever increasing problem.
A brief description of the state of knowledge:
H. pylori is a species representing multiple strains with distinct regional genetic markup. Its prevalence is high in the general population, but in the recent years there have been reports of decreased presence in the developed countries. This paper reviews most important known genetic diversity markers and their impact on virulence and toxicity of species. It also covers possible new ways to combat the infection.
With increased possibility of genetic sequencing, there may be possibility for custom-tailored eradication therapy of H. pylori in the future.
Marshall BJ. One Hundred Years of Discovery and Rediscovery of Helicobacter pylori and Its Association with Peptic Ulcer Disease. In: Mobley HLT, Mendz GL, Hazell SL, editors. Helicobacter pylori: Physiology and Genetics. Washington (DC): ASM Press; 2001. Chapter 3. Available from: https://www.ncbi.nlm.nih.gov/books/NBK2432/
Burucoa, C, Axon, A. Epidemiology of Helicobacter pylori infection. Helicobacter. 2017; 22(Suppl. 1):e12403. https://doi.org/10.1111/hel.12403
Leja, M, Grinberga, I, Bilgilier, C, Steininger, C. Review: Epidemiology of Helicobacter pylori infection. Helicobacter. 2019; 24(Suppl. 1):e12635. https://doi.org/10.1111/hel.12635
IAC MONOGRAPHS ON THE EVALUATION OF CARCINOGENIC RISKS TO HUMANS Volume 61 Schistosomes, Liver Flukes and Helicobacter pylori 1994; page 220 ISBN 92 832 1261 4
Zendehdel, A, Roham, M. Biological evidence of the relationship between Helicobacter pylori and associated extragastric diseases. J Cell Biochem. 2019; 120: 12128‐ 12140. https://doi.org/10.1002/jcb.28681
Malfertheiner P, Megraud F, O'Morain CA on behalf of the European Helicobacter and Microbiota Study Group and Consensus panel, et al Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report Gut 2017;66:6-30.
Mourad-Baars, Petronella E.C.a; Verspaget, Hein W.b; Mertens, Bart J.A.c; Luisa Mearin, M.a d Low prevalence of Helicobacter pylori infection in young children in the Netherlands, European Journal of Gastroenterology & Hepatology: March 2007 - Volume 19 - Issue 3 - p 213-216 doi: 10.1097/MEG.0b013e328011050f
Breckan, R.K., Paulssen, E.J., Asfeldt, A.M., Kvamme, J.‐M., Straume, B. and Florholmen, J. (2016), The All‐Age Prevalence of Helicobacter pylori Infection and Potential Transmission Routes. A Population‐Based Study. Helicobacter, 21: 586-595. doi:10.1111/hel.12316
Mitchell, H. and Katelaris, P. (2016), Epidemiology, clinical impacts and current clinical management of Helicobacter pylori infection. Medical Journal of Australia, 204: 376-380. doi:10.5694/mja16.00104
Urita, Y., Watanabe, T., Kawagoe, N., Takemoto, I., Tanaka, H., Kijima, S., Kido, H., Maeda, T., Sugasawa, Y., Miyazaki, T., Honda, Y., Nakanishi, K., Shimada, N., Nakajima, H., Sugimoto, M. and Urita, C. (2013), Helicobacter pylori status in large family. J Paediatr Child Health, 49: 394-398. doi:10.1111/jpc.12191
Thorell, K, Lehours, P, Vale, FF. Genomics of Helicobacter pylori. Helicobacter. 2017;22(Suppl. 1):e12409. https://doi.org/10.1111/hel.12409
Whitmire J.M., Merrell D.S. (2019) Helicobacter pylori Genetic Polymorphisms in Gastric Disease Development. In: Kamiya S., Backert S. (eds) Helicobacter pylori in Human Diseases. Advances in Experimental Medicine and Biology, vol 1149. Springer, Cham. https://doi.org/10.1007/5584_2019_365
Šterbenc A, Jarc E, Poljak M, Homan M. Helicobacter pylori virulence genes. World J Gastroenterol. 2019;25(33):4870-4884. doi:10.3748/wjg.v25.i33.4870
Hashemi SJ, Sheikh AF, Goodarzi H, et al. Genetic basis for metronidazole and clarithromycin resistance in Helicobacter pylori strains isolated from patients with gastroduodenal disorders. Infect Drug Resist. 2019;12:535-543. Published 2019 Mar 4. doi:10.2147/IDR.S192942
Alba, Claudioa,∗; Blanco, Anaa,∗; Alarcón, Teresaa,b Antibiotic resistance in Helicobacter pylori, Current Opinion in Infectious Diseases: October 2017 - Volume 30 - Issue 5 - p 489-497 doi: 10.1097/QCO.0000000000000396
How to Cite
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Number of views and downloads: 142
Number of citations: 0